Diabete Mellitus, Type 1 Diabetes Mellitus
Conditions
Keywords
Diabetes mellitus, Type 1 Diabetes Mellitus, Hybrid Closed Loop, Automated Insulin Delivery, Patient survey, Survey
Brief summary
Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs. The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.
Detailed description
This is a cross-sectional online survey study, which involves people with type 1 diabetes who use closed-loop, wait to start closed-loop or considering closed-loop. The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy. The secondary objectives of the study are: * To understand what treatment satisfaction with closed-loop therapy means to people living with type 1 diabetes * To understand what additional support is needed for people with type 1 diabetes using closed-loop therapy
Interventions
None listed
Sponsors
University of Nottingham
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Age: ≥18 years (no upper age limit) * Type 1 diabetes (any duration) * People who use closed-loop therapy or wait to start closed-loop therapy or considering closed-loop therapy in the future * Ability to give informed consent
Exclusion criteria
* Any other type of diabetes apart from type 1 diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ranking of factors influencing the choice of closed-loop therapy among people with type 1 diabetes | Day 1 |
Secondary
| Measure | Time frame |
|---|---|
| Ranking of factors contributing to treatment satisfaction with closed-loop therapy | Day 1 |
| Distribution of responses to 5-point Likert scale questions assessing factors contributing to treatment satisfaction with closed-loop therapy | Day 1 |
| Distribution of responses to 5-point Likert scale questions assessing the support needs of people using closed-loop therapy | Day 1 |
| Associations of demographics and reported glucose levels with factors influencing the choice of closed-loop therapy | Day 1 |
| Associations of demographics and reported glucose levels with factors contributing to treatment satisfaction with closed-loop therapy | Day 1 |
| Associations of demographics and reported glucose levels with support needs related to closed-loop therapy | Day 1 |
Countries
United Kingdom
Outcome results
None listed